Cristina Gonzalez Crespo Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr #2, Km 122.0, Bo. Caimital Alto, Aguadilla, PR 00603 Phone: 939-312-3566 |
Belinda Mendez, MS, OTL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr 107 Km 28.5, Edificio Manuel Garcia, Aguadilla, PR 00605 Phone: 787-891-4875 |
Mr. Jose M. Alicea, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr 2 Km 126.4, Bo Caimital Bajo, Aguadilla, PR 00603 Phone: 787-882-3230 |
Joana Judith Velez, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2 St Km 124.7, Caimital Bajo, Aguadilla, PR 00603 Phone: 939-644-8859 Fax: 787-891-6981 |
Xiomara Camacho-gonzalez Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: Carr. 107, Km 2.7 Bo. Borinquen, Aguadilla, PR 00605 Phone: 787-370-9885 |
News Archive
Results from a large, national clinical trial show that corneal donor tissue can be safely stored for 11 days without negatively impacting the success of transplantation surgery to restore vision in people with diseases of the cornea.
A review of scientific studies that compares two treatments for preventing strokes due carotid artery disease provides no clear answer on which treatment is better, a UT Southwestern Medical Center physician reports in an editorial in today's issue of the Archives of Internal Medicine.
Child abuse is a serious problem that affects nearly one million children a year in the United States alone. The American Academy of Pediatrics and the US Department of Health and Human Services classify child abuse into four categories including neglect, physical abuse, sexual abuse, and emotional abuse. None of these categories, however, clearly includes the abusive use of drugs on children. A study soon to be published in the Journal of Pediatrics investigates the malicious use of pharmaceuticals and attempts to shed light on this under-recognized problem.
Geron Corporation today announced that it has entered into a collaboration jointly funded by Geron and a University of California Discovery Research and Training Grant to investigate the therapeutic potential of its human embryonic stem cell (hESC)-based product, GRNOPC1, for Alzheimer's disease. The company is currently developing GRNOPC1 for the potential treatment of spinal cord injury.
Researchers at the Francis Crick Institute have uncovered an important process in how our immune system detects signs of disease and activates a protective response. This understanding could improve efforts to find new and effective immunotherapy treatments for diseases like cancer.
› Verified 4 days ago